Skip to main content

Equibles does not estimate personal net worth.

About Michael D. Kaswan

Michael D. Kaswan is recorded as CFO at Orchestra BioMed Holdings, Inc. (OBIO) since January 26, 2023. Orchestra BioMed Holdings, Inc. reported in an 8-K filed January 31, 2023 that Michael D. Kaswan was appointed Chief Financial Officer, effective January 26, 2023. Orchestra BioMed Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Orchestra BioMed Holdings, Inc. includes David Hochman (CEO and Board Member), David P. Hochman (CEO and Board Member), Andrew L. Taylor (CFO) and 7 others.

“● Michael D. Kaswan, Chief Financial Officer.”
Orchestra BioMed Holdings, Inc. Form 8-K, filed January 31, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Orchestra BioMed Holdings, Inc.

Recent activity